A sugar-coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD-19: An Editorial Highlight for \'Selective inhibition of anti-MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer\'on page 486.